Big Pharma's scoop up companies with drugs that achieve "statistical significance". PTCT hasn't produced that yet, and probably never will. Don't hold your breath waiting for any pharma to open up the vault for "clinically meaningful"............. Which in pharma speak = FAILED.
Me? I prefer drug candidates that achieve statistical significance. There is ONLY one company with results like that in the DMD space, and it isn't PTCT.
You should cover. To argue that PTCT has more downside than upside from this price is silly. PTCT is a big winner over time. To argue that there is any similarity between it and ECYT other than that they are both bios is silly........Who knows, you might have more chances to cover, I would take them, if they occur and change sides. I did. Then again, maybe it is already too late?